Issue of Equity to Vendors of CST Wealth
Source: RNS15 November 2024
BROOKS MACDONALD GROUP PLC
(the "Company")
Issue of Equity to Vendors of CST Wealth Management
Further to the Company's announcement regarding the acquisition of CST Wealth Management ("CST"), Brooks Macdonald, a leading wealth management firm, announces it has issued 30,102 ordinary shares in the Company ("Consideration Shares"). These shares form part of the consideration for the acquisition and have been issued to the vendors of CST.
Admission and Total Voting Rights
Application has been made for the admission of the Consideration Shares to be admitted to trading on AIM ("Admission"). The Consideration Shares will rank pari passu with the existing issued ordinary shares of the Company. It is expected that Admission will become effective and that trading in the new ordinary shares will commence at or around 8.00 am on 21 November 2024.
On Admission, the total number of ordinary shares in the Company will be 16,507,968. The Company does not currently hold any ordinary shares in treasury. Therefore, from Admission, the total number of voting rights in the Company will be 16,507,968, and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Brooks Macdonald Group plc |
+44 (0)20 7927 4816 |
Andrea Montague, CEO
|
|
|
|
Singer Capital Markets (Nominated Adviser and Joint Broker) Charles Leigh-Pemberton / James Moat
|
+44 (0)20 7496 3000 |
Investec Bank plc (Joint Broker) Chris Baird / David Anderson
|
+44 (0)20 7597 4000
|
LEI: 213800WRDF8LB8MIEX37
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.